| ¿µ¹® | carcinoembryonic antigen | ÇÑ±Û | ¾Ï¹è¾ÆÇ׿ø |
|---|---|---|---|
| ¼³¸í | ¿ø·¡ žÆÀÇ ÀåÁ¶Á÷¿¡¼ Á¤»óÀûÀ¸·Î Á¸ÀçÇÏ´Â ¹°Áú·Î žƱâ ÀÌÈÄ¿¡´Â Á¸ÀçÇÏÁö ¾Ê´Â ¹°ÁúÀÌ´Ù. ±×·¯³ª À§, °£, ÇãÆÄ µîÀÇ ¾ÏÀÌ ÀÖ´Â °æ¿ì¿¡ ¼ºÀο¡¼µµ Á¸ÀçÇÑ´Ù. À̸¦ ÀÌ¿ëÇØ¼ ¾ÏÀÇ Ä¡·áÈ¿°ú ÆÇÁ¤À̳ª Àç¹ß¿©ºÎÀÇ Á¶»ç¿¡ ÀÌ¿ëÇÑ´Ù. |
||
| ¿µ¹® | antigen | ÇÑ±Û | Ç׿ø |
|---|---|---|---|
| ¼³¸í | ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ¾î¶°ÇÑ ¹°Áú. ¿©±â¿¡¼ ¸»Çϴ ƯÀÌÇÑ ¸é¿ª¹ÝÀÀÀ̶õ ºñƯÀÌÀûÀÎ ¸é¿ª¹ÝÀÀ°ú´Â ¹Ý´ëµÇ´Â Àǹ̷Π±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â Ç×ü³ª ±× ¹°Áú¿¡ ´ëÇØ¼ ƯÀÌÇÏ°Ô ¹ÝÀÀÇÒ ¼ö ÀÖ´Â ¼¼Æ÷¸¦ ¸¸µå´Â °ÍÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | nuclear medicine | ÇÑ±Û | ÇÙÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | ¹æ»ç¼ºÀ» ¶ì´Â ÇÙ¹°ÁúÀ» ÀÌ¿ëÇÏ¿© ÀÇÇп¡ ÀÀ¿ëÇÏ´Â Çй®. ´ë°³ ÀÎü¿¡ Å« ÇØ°¡ ¾ø´Â ¹æ»ç¼±¹°ÁúÀ» »ç¿ëÇϸç, ¹Ý°¨±â°¡ ª¾Æ »ç¿ëÈÄ¿¡µµ Å« ÇØ°¡ ¾ø´Ù. ÀÌ·± ÇÙÀÇÇÐÀû ¹°ÁúÀ» ÀÌ¿ëÇÑ ÇÙÀÇÇÐÀû Áø´ÜÀÇ °¡Àå Å« ÀåÁ¡Àº »ýü³»¿¡¼ ÀϾ´Â ±× ±â°üÀÇ ½ÇÁ¦ÀûÀÎ ±â´ÉÀ» ¾Ë¾Æº¼ ¼ö ÀÖ´Ù´Â µ¥ ÀÖ´Ù. ÈçÈ÷ Á¢ÇÏ´Â X-¼±À» ÀÌ¿ëÇÑ Áø´Ü¹æ¹ýÀº ´ÜÁö ±× ¼ø°£¸¸ÀÇ ¿µ»óÀ» Á¢ÇÏ¿© ½ÇÁ¦·Î º¸ÀÌ´Â ºÎÀ§°¡ ¾ó¸¶³ª ±â´ÉÀ» ¼öÇàÇÏ´ÂÁö ¾Ë ¼ö ¾ø´Â ´ÜÁ¡ÀÌ ÀÖÀ¸³ª, ÇÙÀÇÇп¡¼´Â ½ÇÁ¦ÀûÀÎ ±â´ÉÀÇ Á¤µµ¿¡ µû¶ó ¿µ»óÀÌ ³ª¿À°Ô µÇ¹Ç·Î ±â´ÉÆÇº°¿¡ ¾ÆÁÖ À¯¸®ÇÏ´Ù. ÇÏÁö¸¸, Á¤È®ÇÑ ÆÇº°·ÂÀÌ ÀÖ´Â ¿µ»óÀ» ¾ò±â¿¡´Â ºÎÁ·ÇÏ´Ù. ¶ÇÇÑ ÇÙÀÇÇÐÀº Áø´Ü¿ÜÀÇ Ä¡·á¿¡µµ »ç¿ëµÇ´Âµ¥, ¿¹¸¦ µé¾î °©»ó»ùÁ¾¾çÀÇ °æ¿ì ¿©·¯ °÷¿¡ ÀÌ¹Ì ÀüÀ̰¡ µÇ¾î ÀÖÀ» °æ¿ì ¹æ»ç¼±ÇÙÁ¾À» ÀÌ¿ëÇÏ¿© ´Ù¸¥ °÷¿¡ Å« ºÎÀÛ¿ë¾øÀÌ Ä¡·á°¡ °¡´ÉÇÏ´Ù. |
||
| ¿µ¹® | nuclear magnetic resonance(NMR) | ÇÑ±Û | ÇÙÀÚ±â°ø¸í |
|---|---|---|---|
| ¼³¸í | ´Ù¸¥ ¸»·Î MRI=Magnetic Resonance Imaging ÀÚ±â°ø¸í¿µ»óÀ̶ó°íµµ ÇÑ´Ù. ÀÎüÀÇ Àå±â³ª, º´ÀûÀÎ ¸ð¾ç, Á¾¾çÀÇ À§Ä¡, ¸²ÇÁÀýÀÇ ºñ´ë µî¿¡ ´ëÇÑ Áø´ÜÀ» ³»¸®±â À§ÇØ ½ÃÇàÇÏ´Â ¹æ»ç¼±ÇÐÀûÀÎ °Ë»ç¹æ¹ýÀÌ´Ù. ÇöÀç ¸¹ÀÌ ¾²À̰í ÀÖ´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT=computerized tomography)°ú´Â ´Ù¸¥ ¹æ¹ýÀ¸·Î ½ÃÇàÇϸç, ±× ÇØ»óµµ°¡ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù´Â ¶Ù¾î³ª ºñ·Ï °í°¡À̱ä ÇÏÁö¸¸, ¸¹ÀÌ ¾²À̰í ÀÖ´Ù. ¶ÇÇÑ ÀÎü¿¡ ¹«ÇØÇϰí, ¿©·¯ °¡Áö ¸é(plane)¿¡¼ »ç¶÷À» ´ÜÃþ½ÃÄÑ º¼ ¼ö ÀÖ´Ù. ´ÜÁ¡Àº ½ÉÀå¹Úµ¿±â¸¦ ¼³Ä¡ÇÑ »ç¶÷À̳ª, ÁÖÀ§¿¡ ÀÚÀåÀ» ¶ì´Â ¹°Ã¼¸¦ ¸ö¿¡ Áö´Ï°í ÀÖ´Â ÁßȯÀÚ µî¿¡¼´Â ÀÌ¿ëÇÒ ¼ö ¾ø°í, º¹ºÎÀå±â¿¡ ´ëÇÑ Áø´Ü¿¡´Â ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µº¸´Ù ¶³¾îÁö´Â °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. |
||
| PCNA | proliferating cell nuclear antigen |
|---|---|
| EPF | early pregnancy factor; endocarditis parietalis fibroplastica; endothelial proliferating factor; est... |
| HLA | histocompatibility leukocyte antigen; histocompatibility locus antigen; homologous leukocyte antibod... |
| MC | mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med... |
| ACC | accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst... |
| PCNA | Proliferating Cell Nuclear Antigen |
|---|---|
| PCNA LI | proliferating cell nuclear antigen labeling index |
| PCNA | Proliferating Cellular Nuclear Antigen |
| P | proliferating |
| PCNA | Antiproliferating cell nuclear antigen |
proliferating pleurisy (Áõ½Ä¼º È丷¿°
| proliferating cell nuclear antigen | Acidic nuclear protein (33 kD) highly expressed in dividing cells. Interacts with D type cyclins. (18 Nov 1997) |
|---|
| proliferating pleurisy | Pleurisy with a tendency for the proliferation of inflammatory exudate. (05 Mar 2000) |
|---|---|
| proliferating systematised angioendotheliomatosis | A rare generalised cutaneous and visceral intracapillary proliferation of endothelial cells, with vascular thrombosis and obstruction. The condition has been divided into a benign reactive type and a rapidly fatal neoplastic type; however, most of the latter cases have been shown to be intravascular large-cell lymphomas. (05 Mar 2000) |
| proliferating tricholemmal cyst | A solitary tumour of the scalp in elderly women that may ulcerate; microscopically resembles squamous cell carcinoma composed of glycogen-rich clear cells, but is benign. Synonym: proliferating tricholemmal cyst. (05 Mar 2000) |
| rod nuclear cell | <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand. (18 Nov 1997) |
| antigen presenting cell | A cell that carries on its surface antigen bound to MCH Class I or Class II molecules and presents the antigen in this context to T-cells. Includes macrophages, endothelium, dendritic cells and Langerhans cells of the skin. See: MHC restriction, histocompatibility antigens. (18 Nov 1997) |
| antigen-responsive cell | A small lymphocyte that, although not itself an immunologically activated cell, responds to antigenic (immunogenic) stimulus by a process of division and differentiation that results in the production of immunologically activated cells. Synonym: antigen-responsive cell. (05 Mar 2000) |
| antigen-sensitive cell | A small lymphocyte that, although not itself an immunologically activated cell, responds to antigenic (immunogenic) stimulus by a process of division and differentiation that results in the production of immunologically activated cells. Synonym: antigen-responsive cell. (05 Mar 2000) |
| B-cell antigen receptors | In the primary immune response immunoglobulin D and monomeric immunoglobulin M are the B-cell antigen receptors. On memory B-cells, other immunoglobulin molecules can serve as antigen receptors. (05 Mar 2000) |
| gene rearrangement, alpha-chain T-cell antigen receptor | Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors. (12 Dec 1998) |
| gene rearrangement, beta-chain T-cell antigen receptor | Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors. (12 Dec 1998) |
| gene rearrangement, delta-chain T-cell antigen receptor | Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors. (12 Dec 1998) |
| gene rearrangement, gamma-chain T-cell antigen receptor | Ordered rearrangement of T-cell variable gene regions coding for the gamma-chain of antigen receptors. (12 Dec 1998) |
| receptor-CD3 complex, antigen, T-cell | Molecule composed of the non-covalent association of the T-cell antigen receptor (receptors, antigen, T-cell) with the CD3 complex (antigens, CD3). This association is required for the surface expression and function of both components. The molecule consists of up to seven chains: either the alpha/beta or gamma/delta chains of the T-cell receptor, and four or five chains in the CD3 complex. (12 Dec 1998) |
| receptors, antigen, B-cell | Immunoglobulin molecules on the surface of B-lymphocytes that recognise and bind antigen. (12 Dec 1998) |
| receptors, antigen, T-cell | Molecules on the surface of T-lymphocytes that recognise and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (antigens, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (receptors, antigen, T-cell, alpha-beta) or gamma-delta (receptors, antigen, T-cell, gamma-delta) chains. (12 Dec 1998) |
Synonyms : PCNA-Cyclin, PCNA Cyclin
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|